Consun Pharmaceutical Group Ltd. Financial Overview
Consun Pharmaceutical Group Ltd.'s market cap is currently €1.45B. The company's EPS TTM is €0.0704178; its P/E ratio is 11.08; Consun Pharmaceutical Group Ltd. is scheduled to report earnings on August 19, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
